Table 4.
Risk factors for the severity of illness in patients with COVID-19
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | Pvalue | OR | 95% CI | Pvalue | |
Age (years) | ||||||
≥ 66 | 111.8 | 38.7–323.2 | < 0.001 | 56.5 | 17.1–186.5 | < 0.001 |
41–65 | 29.0 | 11.2–74.9 | < 0.001 | 14.8 | 5.2–42.1 | < 0.001 |
19–40 | 16.4 | 6.3–42.3 | < 0.001 | 12.7 | 4.5–35.9 | < 0.001 |
≤ 18 | 1.0 | 1.0 | ||||
Sex (male) | 1.6 | 1.1–2.3 | 0.024 | 1.7 | 1.2–2.6 | 0.008 |
Current smoker | 1.5 | 0.7–3.1 | 0.255 | |||
Family cluster | 0.5 | 0.3–0.8 | 0.007 | 0.9 | 0.5–1.4 | 0.579 |
Exposure History in Wuhan | 1.1 | 0.8–1.6 | 0.608 | |||
Time from illness onset to first hospital admission | 1.1 | 1.0–1.2 | < 0.001 | 1.1 | 1.0–1.1 | 0.071 |
Symptoms | ||||||
Fever | 4.3 | 2.6–7.1 | < 0.001 | 3.6 | 2.1–6.3 | < 0.001 |
Cough | 2.7 | 1.8–4.1 | < 0.001 | 1.7 | 1.0–3.0 | 0.041 |
Sputum production | 2.2 | 1.5–3.4 | < 0.001 | 1.3 | 1.0–2.1 | 0.366 |
Hemoptysis | 7.7 | 2.8–21.3 | < 0.001 | 3.4 | 1.1–10.3 | 0.032 |
Sore throat | 0.8 | 0.4–1.3 | 0.345 | |||
Nasal obstruction | 0.3 | 0.2–0.7 | 0.005 | 0.6 | 0.2–1.4 | 0.223 |
Myalgia | 2.6 | 1.5–4.5 | 0.001 | 1.8 | 1.0–3.4 | 0.063 |
Fatigue | 1.8 | 1.1–2.8 | 0.022 | 1.3 | 0.7–2.2 | 0.371 |
gastrointestinal symptoms | 2.1 | 1.2–3.6 | 0.012 | 1.9 | 1.0–3.5 | 0.047 |
Headache | 2.0 | 1.1–3.6 | 0.030 | 2.0 | 1.0–4.0 | 0.052 |
Coexisting disorder | ||||||
Any | 3.8 | 2.5–5.9 | < 0.001 | 1.2 | 0.6–2.4 | 0.660 |
Hypertension | 4.9 | 3.0–7.8 | < 0.001 | 2.6 | 1.2–5.6 | 0.013 |
Heart disease | 2.5 | 0.6–10.1 | 0.189 | |||
Diabetes | 2.4 | 1.2–4.6 | 0.009 | 0.8 | 0.4–1.9 | 0.675 |
Chronic obstructive pulmonary disease | 42.0 | 4.9–363.9 | 0.001 | 7.7 | 0.8–75.6 | 0.081 |
Cancer | 7.3 | 1.5–35.2 | 0.013 | 3.7 | 0.6–22.2 | 0.149 |
Chronic liver disease | 1.6 | 0.6–3.9 | 0.335 | |||
Chronic renal disease | 4.3 | 0.9–20.6 | 0.065 |
OR Odds ratio, CI Confidence interval